AFAR presents “The Business of Longevity: Moving Biomedical Advances into Biotech Opportunities”

The American Federation for Aging Research (AFAR) invites you to an exclusive event featuring leaders in biotech for healthy aging.

The Business of Longevity: Moving Biomedical Advances into Biotech Opportunities
Wednesday, September 30, 2020
10-11am Eastern Time

To RSVP or for more information, please contact Amy Sullivan at amy@afar.org.

Featuring visionary venture capital investors and aging researchers, the discussion will:

– Introduce how the hallmarks of aging have inspired potential age-targeting drugs,
– Present insights about therapeutics in development, and
– Explore the impact that an FDA Indication for aging would have on future therapeutics.

Panelists include:

Nir Barzilai, MD
Founder – CohBar, Chief Medical Advisor – Life Biosciences, Principal Investigator – TAME Trial, and Scientific Director – AFAR

Mehmood Khan, MD
CEO – Life Biosciences, Board Member – AFAR

Jim Mellon
Chairman – Juvenescence, Ltd., Board Member – AFAR

James Peyer
CEO & Founder – Cambrian Biopharma

Sergey Young
Founder – The Longevity Vision Fund, Board Member – AFAR

Share on twitter
Twitter
Share on linkedin
LinkedIn